Endo International plc is a specialty pharmaceutical company engaged in the research, development, production, and sale of a broad array of branded and generic pharmaceuticals, as well as over-the-cou... Endo International plc is a specialty pharmaceutical company engaged in the research, development, production, and sale of a broad array of branded and generic pharmaceuticals, as well as over-the-counter medications. The company's primary function is to deliver innovative healthcare solutions that improve patient quality of life. Endo International focuses on key therapeutic areas such as pain management, urology, oncology, and endocrinology. By leveraging its research capabilities and investing in advanced drug delivery technologies, Endo International addresses unmet medical needs across various medical fields, impacting healthcare providers and patients alike.
Notable features of the company include its commitment to expanding its product pipeline and its strategic acquisitions that enhance its product offerings. Endo's role in the financial market is significant, as it contributes to both the pharmaceutical industry's innovation landscape and provides opportunities for broader access to critical medications. Based in Dublin, Ireland, with operational facilities across the United States, Endo International continues to play a vital role in addressing complex healthcare challenges through its comprehensive portfolio of products and solutions.